Peter Attia· MD
if he's looking for enlarged thymus in patients he's treating with growth hormone i would be surprised if you did not see that and he did
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if he's looking for enlarged thymus in patients he's treating with growth hormone i would be surprised if you did not see that and he did
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the biologic activity of it is mostly driven not exclusively by igf-1 which used to be called i think somatomedon when we were in medical school we know that lymphoid tissue is probably the most sensitive target organ for igf-1 and it causes hypertrophy